Menu

Investors

Tear Sheet

Tear Sheet

Corporate Profile

We are a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with chronic kidney disease.

Stock Chart

Minimum 15 minutes delayed. Source: LSEG

Stock Quote

Change
Volume
52 Week High
52 Week Low
Events
Date Details
January 16, 2025 at 7:30 AM PST
43rd Annual J.P. Morgan Healthcare Conference
Listen to webcast
December 3, 2024 at 10:30 AM EST
Piper Sandler 36th Annual Healthcare Conference
Listen to webcast
November 21, 2024 at 1:00 PM GMT
Jefferies London Healthcare Conference
Listen to webcast
News Releases

SEC Filings

Filing date Description View

Statement of changes in beneficial ownership of securities
0001562180-25-000453.pdf

Report of unscheduled material events or corporate event
0001517022-25-000004.pdf

A statement of beneficial ownership of common stock by certain persons
0002012383-24-003437.pdf

Report of unscheduled material events or corporate event
0001517022-24-000075.pdf

Quarterly report which provides a continuing view of a company's financial position
0001628280-24-045979.pdf
Print Page
Print Page
Email Page
Email Page
Contact IR
Contact IR
Email Alerts
Email Alerts
Tear Sheet
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us